Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Leukemia × acalabrutinib × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 2 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1

Interventions

zanubrutinib 1 venetoclax 1 ibrutinib 1 acalabrutinib 1 Topotecan 1 Mitoxantrone 1 Etoposide 1 Clofarabine 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06520098 2025-10-14

Benefit VA

VA Office of Research and Development

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡